Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

NCT00826280 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

347

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD)

Interventions

DRUG: regadenoson
DRUG: overencapsulated caffeine
RADIATION: technetium
DRUG: placebo

Sponsor

Astellas Pharma Inc